Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular diagnostics for cardiovascular disease

C P Pang1

  • 1Department of Chemical Pathology, Chinese University of Hong Kong, Shatin, NT. cppang@cuhk.edu.hk

Clinical Chemistry and Laboratory Medicine
|November 7, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic markers for primary open-angle glaucoma using next-generation sequencing: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2025
Same author

Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.

Frontiers in immunology·2022
Same author

Association of Optical Coherence Tomography Angiography Metrics With Detection of Impaired Macular Microvasculature and Decreased Vision in Amblyopic Eyes: The Hong Kong Children Eye Study.

JAMA ophthalmology·2020
Same author

Isolation and identification of bioactive substance 1-hydroxyphenazine from Pseudomonas aeruginosa and its antimicrobial activity.

Letters in applied microbiology·2020
Same author

Genetic prediction models for primary open-angle glaucoma: translational research.

Hong Kong medical journal = Xianggang yi xue za zhi·2020
Same author

Exome sequencing to reveal presymptomatic genetic markers for primary open angle glaucoma.

Hong Kong medical journal = Xianggang yi xue za zhi·2019
Same journal

Fish-shaped erythrocytes and pincer cells co-occur in distinct hematological disorders and are associated with anemia severity.

Clinical chemistry and laboratory medicine·2026
Same journal

Artificial general intelligence and the clinical laboratory: a paradigm shift toward Lab 2.0.

Clinical chemistry and laboratory medicine·2026
Same journal

Addressing property and unit discordance in laboratory interoperability: the role of NPU as a governance layer.

Clinical chemistry and laboratory medicine·2026
Same journal

Ethical evaluation of reflex and reflective testing in conformity with ISO 15189:2022 at the value-based laboratory medicine era.

Clinical chemistry and laboratory medicine·2026
Same journal

Emerging blood-based diagnostic strategies for tuberculosis.

Clinical chemistry and laboratory medicine·2026
Same journal

Homocitrulline and 3-year mortality in older hospitalised adults: an exploratory study.

Clinical chemistry and laboratory medicine·2026
See all related articles

Cardiovascular disease has multiple causes, including genetics and lifestyle. Molecular genetics aids in diagnosing gene defects for personalized treatment and prevention, but more research is needed.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cardiology

Background:

  • Cardiovascular diseases (CVD) stem from multifactorial causes, including lifestyle and genetic predispositions.
  • Specific gene defects and complex gene-environment interactions contribute to CVD.
  • Advances in molecular genetics have identified gene aberrations linked to CVD and lipid disorders.

Purpose of the Study:

  • To explore the role of molecular genetics in understanding and diagnosing cardiovascular diseases.
  • To highlight the potential of genetic testing for personalized drug therapy and genetic counseling.
  • To emphasize the need for comprehensive identification and prevalence studies of gene alterations in CVD.

Main Methods:

  • Application of molecular biology techniques for gene defect detection.

Related Experiment Videos

  • Identification of gene aberrations associated with lipidaemic and vascular disorders.
  • Review of current knowledge on genetic factors in cardiovascular disease etiology.

    • Main Results:

    • Molecular genetics enables rapid and reliable detection of specific gene defects.
    • Pre-symptomatic diagnosis and carrier identification are possible for effective preventive measures.
    • Numerous gene mutations are associated with cardiovascular disease, requiring further population-based studies.

    Conclusions:

    • Molecular diagnostics offer significant benefits for CVD management, including tailored drug therapy and genetic counseling.
    • Further research is essential to identify all causative gene alterations and their prevalence across diverse populations.
    • Future development of cost-effective methodologies will enhance the accessibility of genetic testing for cardiovascular health.